NFKB1 and Familial prostate cancer: This deregulation of IL-6 expression in prostate cancer cells is in fact mostly mediated by the constitutive NF-κB activation [61], and this activation occurs through signal transduction involving the upstream effectors NF-κB inducing kinase (NIK) and IKK.